Core Viewpoint - The IPO of Ying's Holdings Group Co., Ltd., primarily focused on infant complementary food, was successfully approved by the Beijing Stock Exchange on December 22, 2025, with a product matrix that also includes infant hygiene products, children's food, and nutritional products [2][12]. Group 1: Business Operations - Ying's Holdings has seen a year-on-year increase in transaction scale with key partners, covering both sales and procurement, with procurement service fees rising over time [2][12]. - The company has established a strong partnership with Kid's King, which has consistently been its second-largest customer during the reporting period, with sales figures of 60.41 million, 81.29 million, 79.10 million, and 39.53 million yuan, representing 71.17%, 94.69%, 95.30%, and 91.00% of offline direct sales respectively [4][14]. - The average selling price of infant complementary food has shown an upward trend, attributed to increased promotional efforts and reduced sales discounts [4][14]. Group 2: Financial Performance - The procurement service amounts from Ying's Holdings to Kid's King and its affiliates have increased from 8.53 million to 11.86 million yuan from 2021 to the first half of 2025, with the procurement service fee rate rising from 17.07% to 27.53% [5][15]. - Four investment firms, including Nanjing Xingna Yi, have exited their investments in Ying's Holdings, collectively realizing over 37 million yuan in gains [6][15]. Group 3: Shareholder Dynamics - The actual controller's relative, Lin Shaobo, was a former hidden shareholder and has connections to significant offline distributors, with Ying's Holdings reporting sales to these distributors of 10.97 million, 15.32 million, 13.72 million, and 6.08 million yuan during the reporting period [7][16]. - Lin Shaobo's associated companies have been involved in the distribution of infant food products, although the sales margins were lower than the average for offline distribution channels [17]. Group 4: Internal Control Issues - Ying's Holdings has faced internal control issues related to non-legal distributors, with significant amounts of orders placed via phone and WeChat, totaling 0.51 million, 0.91 million, 0.79 million, and 0.45 million yuan during the reporting period [9][18]. - The company reported unbilled income of 187.79 million yuan in 2022, accounting for 49.50% of the revenue from the distribution channel, which has since been resolved starting in 2023 [9][18].

Core Insights - The infant and toddler complementary food industry in China is experiencing significant activity, with leading companies Ying's Holdings and Grandpa's Farm racing to go public [2][4] - The market size for infant complementary food in China is projected to surpass that of the EU and Japan by 2024, making it the second largest market after the US [5] - The industry is highly fragmented, with the top five brands holding only a 14.2% market share, indicating potential for consolidation [7] Company Overview - Ying's Holdings, established in 2014, has a diverse product range including infant food and hygiene products, and has consistently ranked first in market share from 2022 to 2024 [10][11] - Grandpa's Farm, founded in 2015, has shown rapid growth, ranking second in total transaction volume for 2024 and leading in the organic infant complementary food segment [13] - Ying's Holdings reported a revenue of 1.974 billion yuan for 2024, while Grandpa's Farm reported 875 million yuan [15] Growth and Profitability - Grandpa's Farm has a remarkable compound annual growth rate (CAGR) of 42.6% from 2022 to 2024, with a year-on-year growth of 40.6% in 2024 [17] - Ying's Holdings experienced a revenue growth rate of only 12.3% in 2024, indicating potential growth challenges [17] - In terms of profitability, Ying's Holdings' net profit decreased by 4.4% in 2024, while Grandpa's Farm's profits have been steadily increasing [17] Market Positioning - Ying's Holdings focuses on a "scientific five-stage precise feeding system," while Grandpa's Farm emphasizes high-end organic products, priced approximately 30% higher than Ying's [19][21] - Both companies face challenges related to brand recognition and market perception, with Ying's Holdings dealing with trademark disputes and Grandpa's Farm facing scrutiny over its dividend payouts [22][24] Production and Quality Control - Ying's Holdings employs a mixed production model with about 55.1% of its products outsourced, raising concerns about quality control due to past consumer complaints [25][27] - Grandpa's Farm previously relied entirely on third-party manufacturing, which led to issues with product quality and compliance with safety standards [26][27] - Both companies have low research and development (R&D) spending relative to their revenues, indicating a reliance on marketing over product innovation [28] Industry Challenges - The infant food industry is characterized by high marketing expenses and low R&D investment, which could hinder long-term sustainability [28][30] - The future of the infant complementary food industry will likely depend on a return to product quality, enhanced R&D capabilities, and building a strong brand image [32]

Core Viewpoint - Ying's Holdings has successfully passed the IPO review at the Beijing Stock Exchange, aiming to become the "first stock in baby food" and the first new food company listed in nearly three years on the exchange. However, the company faces significant operational challenges, including a long-standing tendency to prioritize marketing over research and development, quality control pressures from its reliance on an OEM model, and unresolved trademark disputes [1][2]. Financial Performance - Ying's Holdings expects revenue for the first half of 2025 to reach between 2.213 billion and 2.295 billion yuan, representing a year-on-year growth of 12.11% to 16.26%. The net profit attributable to the parent company is projected to be between 235 million and 246 million yuan, with a growth rate of 11.44% to 16.58% [3][5]. - The company's sales expenses have significantly increased, with projections for 2024 reaching 6.02 billion yuan and 7.21 billion yuan for 2025, resulting in sales expense ratios of 34.26% and 36.53%, respectively, which are well above the industry average of approximately 27% [6][5]. Marketing and R&D Strategy - Ying's Holdings has a pronounced "heavy marketing, light R&D" characteristic, with marketing expenses rising sharply while R&D investment remains low. R&D expenses from 2022 to 2024 were 5.53 million, 9.21 million, and 17.15 million yuan, respectively, with R&D expense ratios below 1%, compared to an industry average of about 2% [6][8]. - The company's marketing strategy has led to a significant increase in platform promotion costs, which rose from 151 million yuan in 2022 to 300 million yuan in 2024, accounting for 41.6% of total sales expenses [6][7]. Production Model and Quality Control - Ying's Holdings relies heavily on an OEM production model, with the proportion of outsourced production increasing from 39.83% in 2022 to 55.10% in 2024. This model raises concerns about quality control, especially in the sensitive baby food sector [10][11]. - The company has faced quality issues with some of its OEM partners, leading to administrative penalties and the termination of contracts. The company reported a rising number of consumer complaints related to product quality during the reporting period [12][14]. Trademark Disputes - Ying's Holdings is involved in a trademark dispute with "YeeHoO," a brand under the Hailan Home Group, which has created uncertainty for the company's future. The dispute centers around the use of the "Ying's" trademark, with ongoing legal proceedings that could impact the company's operations [14][15]. - The company has indicated that the outcome of this trademark dispute could significantly affect its brand value and market confidence, especially given its heavy reliance on brand marketing [15].

Core Viewpoint - Ying's Holdings has successfully passed the IPO review at the Beijing Stock Exchange, aiming to become the "first stock in baby food" and the first new food company listed in nearly three years on the exchange. However, the company faces significant operational challenges, including a long-standing tendency to prioritize marketing over research and development, reliance on an OEM model leading to quality control pressures, and unresolved trademark disputes [2][4][18]. Group 1: Financial Performance - Ying's Holdings' main business segments are infant food and hygiene products, with infant food revenue reaching 864 million yuan in the first half of 2025, accounting for 76% of total revenue. The company expects revenue for 2025 to be between 2.213 billion and 2.295 billion yuan, representing a year-on-year growth of 12.11% to 16.26%, and a net profit attributable to shareholders of 235 million to 246 million yuan, with a growth of 11.44% to 16.58% [4][5]. - The company's sales expenses have significantly increased, with figures of 454 million yuan, 602 million yuan, and 721 million yuan from 2022 to 2024, resulting in sales expense ratios of 35.04%, 34.26%, and 36.53%, which are well above the average of about 27% for comparable companies [6][9]. - In contrast, R&D expenditures have been minimal, with amounts of 5.53 million yuan, 9.21 million yuan, and 17.15 million yuan from 2022 to 2024, resulting in R&D expense ratios below 1%, significantly lower than the average of about 2% for comparable companies [9][10]. Group 2: Operational Challenges - The company heavily relies on an OEM model, with the proportion of outsourced production increasing from 39.83% in 2022 to 55.10% in 2024. This model poses quality control risks, especially in the sensitive infant food sector [13][14]. - There have been quality issues with some of the company's OEM partners, leading to administrative penalties and the termination of partnerships. The company has faced numerous consumer complaints regarding product quality, which raises concerns about its ability to manage quality control effectively [15][18]. Group 3: Legal Risks - Ying's Holdings is involved in a trademark dispute with "YeeHoO," a high-end baby clothing brand, which adds uncertainty to its future. The company has filed a lawsuit against YeeHoO and others for trademark infringement, seeking damages of 600,000 yuan [18][19]. - The outcome of this trademark dispute is critical, as a negative result could severely impact the company's brand and market confidence, given its heavy reliance on brand marketing and the significant sales expenses exceeding 700 million yuan [19][20].

Core Viewpoint - Ying's Holdings Group Co., Ltd. is applying for an IPO, focusing on infant food, hygiene products, and children's food, with a significant revenue contribution from infant complementary food, which has a gross margin of 62.26% in the first half of this year, outperforming the industry average of 48.2% [1] Financial Performance - The gross margin for Ying's infant complementary food is 62.26%, while the gross margin for infant hygiene products is 43.77%, both exceeding their respective industry averages [1] - The gross margin for Ying's infant rice flour is nearly 70%, indicating a cost of only 30 yuan for every 100 yuan sold [1] - The gross margins for various product categories in recent years are as follows: - Rice flour: 69.45% in 2025 H1, 66.56% in 2024, 68.38% in 2023, and 68.40% in 2022 [2] - Biscuits: 54.51% in 2025 H1, 54.36% in 2024, 55.77% in 2023, and 56.66% in 2022 [2] - Noodles: 59.16% in 2025 H1, 59.07% in 2024, 57.22% in 2023, and 58.69% in 2022 [2] R&D Investment - Ying's Holdings has a low R&D investment as a percentage of revenue, at 0.87% for 2024 and 0.71% for 2025 H1, significantly below the industry average of 2.03% and 1.75% [2][3] - Despite lower R&D spending, the company achieves higher product gross margins compared to industry averages [3] Production and Quality Control - The company claims that its infant rice flour is produced by its wholly-owned subsidiary, but there are discrepancies in disclosures regarding the use of contract manufacturers for production [3] - The company acknowledges challenges in quality control due to the use of contract manufacturing, which could impact its operations and brand reputation if quality issues arise [5] - There have been multiple complaints regarding product safety on consumer platforms, indicating potential concerns about product quality [5]

Core Viewpoint - Ying's Holdings Group Co., Ltd. has been approved for listing on the Beijing Stock Exchange, marking the 100th company to pass the review this year [1]. Group 1: Company Overview - Ying's Holdings is a comprehensive and large-scale enterprise focused on the research, production, and operation of maternal and infant products, including infant food and hygiene products [1]. - The company has no controlling shareholder, with actual control held by Ma Wenbin, Wan Jianming, and Peng Min, who collectively control 52.02% of the shares [2]. Group 2: IPO Details - Ying's Holdings plans to publicly issue up to 13.0898 million shares, aiming to raise approximately 333.9564 million yuan for various projects, including the construction of an innovation center and production projects for infant nutrition products [3]. - The underwriting institution for the IPO is Western Securities Co., Ltd., marking its second successful IPO project this year [1][3]. Group 3: Review and Inquiry - The review committee raised inquiries regarding the authenticity and sustainability of revenue growth, as well as the quality control measures for products produced by third-party manufacturers [5].

Core Viewpoint - Ying's Holdings Group Co., Ltd. has received approval from the North Exchange's listing committee for its initial public offering (IPO), aiming to meet the nutritional care needs of infants and young children in China [1] Financial Performance - The company reported revenues of 1.296 billion yuan, 1.758 billion yuan, and 1.974 billion yuan for the years 2022, 2023, and 2024 respectively, indicating a growth trajectory [1] - Net profits for the same years were 117.33 million yuan, 220.20 million yuan, and 210.59 million yuan, showing fluctuations in profitability [1] - Key financial metrics for 2024 include: - Revenue: 1.974 billion yuan - Net profit attributable to shareholders: 210.60 million yuan - Basic and diluted earnings per share: 1.40 yuan - Return on equity: 24.38% - Net cash flow from operating activities: 292.39 million yuan [1] Business Focus - The company operates in two main segments: infant food and hygiene products, focusing on comprehensive development to cater to the needs of mothers and infants [1] - The funds raised from the IPO will be allocated to brand building, production line upgrades, the establishment of an innovation center in Hunan, and the construction of a ready-to-eat infant nutrition porridge production facility [1]

Core Viewpoint - The IPO review process in December 2025 has accelerated, with a record number of companies scheduled for review, indicating a robust pipeline for new listings in the Chinese capital markets [1][6]. Group 1: IPO Review Acceleration - A total of 25 companies have been scheduled for IPO reviews in December, setting a new monthly record for the year [6]. - Among the 25 companies, 12 are from the North Exchange, 6 from the Growth Enterprise Market, 4 from the main board, and 3 from the Sci-Tech Innovation Board [6]. - The highest fundraising target is set by Vision Technology, aiming to raise approximately 2.015 billion yuan [7]. Group 2: Notable Companies and Their IPOs - Ying's Holdings successfully passed its IPO review on December 22, aiming to raise about 334 million yuan, focusing on infant nutrition and hygiene products [3][5]. - DaPu Microelectronics is notable as the first unprofitable company to apply for an IPO on the Growth Enterprise Market, with a fundraising target of approximately 1.878 billion yuan [4][5]. - MoLong Co., primarily engaged in the production and sales of molybdenum-related products, is set for review on December 23 [3]. Group 3: Financial Performance and Projections - Vision Technology reported revenues of approximately 190 million yuan in 2022, with projected losses of 2.47 billion yuan for the same year, and aims to achieve profitability by 2026 [7][10]. - DaPu Microelectronics reported revenues of 556 million yuan in 2022, with a net loss of 534 million yuan, and aims to improve its financial performance in the upcoming quarters [10][11]. - Feng En Co., an eco-friendly fabric supplier, has seen rising accounts receivable, with values increasing from 246 million yuan to 354 million yuan over the reporting periods [5]. Group 4: Industry Trends - The majority of the companies undergoing IPO reviews are in the "hard technology" sector, which includes industries such as power semiconductors, new energy batteries, and medical devices [9][10]. - The acceleration of IPO reviews for "hard technology" companies is attributed to their core technologies and alignment with national strategic interests, which enhances their appeal to investors [10][13].

Core Viewpoint - The IPO review process in December has accelerated, with a record number of companies scheduled for meetings, indicating a robust pipeline for new listings in the market [1][6]. Group 1: IPO Review Acceleration - From December 22 to 26, nine companies including Sanrui Intelligent and New Hengtai were scheduled for IPO meetings, setting a new high for the year [1][3]. - As of December 22, a total of 25 IPOs have been arranged for review in December, marking a monthly record [6]. - The North Exchange leads with 12 companies scheduled for IPO meetings, followed by the Growth Enterprise Market with 6, and the Main Board with 4 [6]. Group 2: Notable Companies and Fundraising - Vision Technology, aiming for the Sci-Tech Innovation Board, plans to raise approximately 2.015 billion yuan, the highest among the listed companies [1][7]. - Dapu Micro, notable for being the first unprofitable company to apply for an IPO on the Growth Enterprise Market, plans to raise about 1.878 billion yuan [4][10]. - Other companies scheduled for meetings include Ying's Holdings, which aims to raise around 334 million yuan, and Fuen Co., which plans to raise approximately 1.25 billion yuan [3][4]. Group 3: Financial Performance and Industry Focus - Vision Technology reported revenues of approximately 190 million yuan in 2022, with projected losses in subsequent years, but anticipates profitability by 2026 [7][10]. - Dapu Micro's revenues for 2022 to 2024 were approximately 557 million yuan, 519 million yuan, and 962 million yuan, with significant losses reported [10]. - Fuen Co. focuses on sustainable development and has seen an increase in accounts receivable, which raises concerns about its financial health [5]. Group 4: Industry Trends - The majority of companies undergoing IPO reviews are concentrated in the "hard technology" sector, which includes industries such as power semiconductors and medical devices [9][12]. - The acceleration of IPO reviews for "hard technology" companies is attributed to their core technologies and broad industry prospects, aligning with national strategic interests [9][12].

Core Viewpoint - This week, a total of 9 companies are scheduled for IPO meetings across various stock exchanges, with significant fundraising amounts expected, particularly from Vision Technology, which aims to raise 2.015 billion yuan [1]. Group 1: Upcoming IPOs - Nine companies will present their IPO applications from December 22 to December 26, with the highest fundraising target set by Vision Technology at 2.015 billion yuan [1]. - The companies include: - Fuen Co., Ltd. and Shenglong Co., Ltd. targeting the Shenzhen Main Board [1]. - Vision Technology aiming for the Sci-Tech Innovation Board [1]. - Sanrui Intelligent and Dapu Micro targeting the Growth Enterprise Market [1]. - Xinhengtai and Puan Medical, among others, targeting the Beijing Stock Exchange [1]. Group 2: Fundraising Amounts - Vision Technology plans to use the raised funds for the expansion of its ultra-high-resolution silicon-based OLED micro-display production line and R&D center [1]. - Dapu Micro and Shenglong Co., Ltd. follow with fundraising targets of 1.878 billion yuan and 1.530 billion yuan, respectively [1]. Group 3: Company Profiles - Shenglong Co., Ltd. is a leading large-scale molybdenum company focused on the comprehensive development and utilization of non-ferrous metal mineral resources [2]. - Fuen Co., Ltd. specializes in the research, production, and sales of eco-friendly fabrics [3]. - Dapu Micro is engaged in the research and sales of enterprise-level SSD products for data centers [4]. - Sanrui Intelligent focuses on the R&D, production, and sales of electric power systems for drones and robots [5]. - Vision Technology is a global leader in micro-display solutions, offering silicon-based OLED micro-displays and value-added services [6]. - Ying's Holdings operates in the infant nutrition and care sector, producing a range of baby products [7]. - Longyuan Co., Ltd. specializes in the R&D, production, and sales of aluminum alloy precision die-casting parts [8]. - Puan Medical focuses on the R&D, production, and sales of medical devices for diabetes care and minimally invasive interventions [9]. - Xinhengtai is involved in the R&D, manufacturing, and sales of plastic foaming materials [10].